- Assembly Biosciences ( NASDAQ: ASMB ) on Wednesday said its current CEO John McHutchison would step down at the end of the year.
- The company's board selected current president and COO Jason Okazaki to succeed McHutchison as top boss, ASMB said in a statement .
- McHutchison will continue to serve on ASMB's board, and will assume the role of chairman of the science and technology committee.
- ASMB said Okazaki had joined the company as chief legal and business officer in 2020. He was then promoted to COO in 2022 and elevated to president earlier this year.
- According to ASMB, prior to joining the company, Okazaki had a 14-year career at Gilead Sciences ( GILD ).
For further details see:
Jason Okazaki to succeed John McHutchison as Assembly Biosciences CEO at year-end